Jan 15
心脏生物科技解决方案激活MyCardia AT中国生产流程并进入NMPA最终申报阶段
CBSC activates China manufacturing pipeline and enters final NMPA submission phase for MyCardia AT cardiac monitoring device.
Jan 15
CBSC activates China manufacturing pipeline and enters final NMPA submission phase for MyCardia AT cardiac monitoring device.
May 08
CB Scientific, Inc. is now Cardiac Biotech Solutions, Inc., reflecting our mission to deliver advanced, cloud-connected cardiac monitoring technologies across global healthcare markets.
Sep 06
Updated product to include significant operating improvements and material design advances over the current offering
Aug 23
Shenzhen Pump Medical Co. Ltd. to formally become the recognized manufacturer of record for CBSC’s myCam device, cloud-based software, and smartphone app in China.
Dec 07
Partnership to provide high-volume manufacturing capability and facilitate obtaining requisite government approvals.
Feb 11
Companies to form a strategic partnership to collaborate on new monitoring solutions for growing international remote cardiac monitoring markets.